Companies / South Korea
Relax DTC Advertising Laws, Say Multinationals
November 2006 | Industry NewsThroughout most of the developed world, governments play an important guardian role when it comes to the pharmaceutical industry in terms of restricting prices and prohibiting direct-to-consumer (DTC) advertising. In fact, only two countries, New Zealand and the US, allow DTC drug promotion, with the consensus holding that the practice endangers the health of patients. However, in South Korea, some industry observers are beginning to examine the case for amending the Pharmaceuticals Affairs Act and relaxing strict rules on drug
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
